<?xml version="1.0" encoding="UTF-8"?>
<p>In the setting of the 2012 MERS‐CoV syndrome, despite some similarities with SARS‐CoV, the early mortality rate for the former achieved 60%,
 <xref rid="jce14479-bib-0010" ref-type="ref">
  <sup>10</sup>
 </xref> remaining higher than 35% during the overall outbreak period, while for SARS‐CoV the mortality rate was about 10%.
 <xref rid="jce14479-bib-0011" ref-type="ref">
  <sup>11</sup>
 </xref> A meta‐analysis suggested that MERS‐CoV infection was more likely to occur in patients with underlying cardiovascular diseases.
 <xref rid="jce14479-bib-0012" ref-type="ref">
  <sup>12</sup>
 </xref> In terms of overall complications, renal failure (40.9%), cardiac arrhythmias (15.7%), hepatic dysfunction (31.4%),
 <xref rid="jce14479-bib-0013" ref-type="ref">
  <sup>13</sup>
 </xref> besides pericarditis, and hypotension were the most commonly reported.
 <xref rid="jce14479-bib-0014" ref-type="ref">
  <sup>14</sup>
 </xref> In a case report published by Alhogbani, he describes an acute myocarditis caused by MERS‐CoV; a 60‐year‐old presenting with respiratory symptoms, chest pain, and persistent tachycardia (120 bpm). Echocardiogram demonstrated severe left ventricular function impairment, cardiac magnetic resonance showed typical findings of acute myocarditis, and sputum was positive for MERS‐CoV. The patient was intubated and required hemodialysis. After 6 weeks of intensive care unit (ICU) and 1 month of ward hospitalization, he was discharged in stable condition.
 <xref rid="jce14479-bib-0015" ref-type="ref">
  <sup>15</sup>
 </xref>
</p>
